Alex Mueller

This inventor holds 6 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Endogena Therapeutics, Inc.. Active years: 2020-2026.

USPTO Granted Patents = 6 (Patent Applications = 2)

% Patents Active = 66.7

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

6 out of 6

Endogena Therapeutics, Inc.

patents

Years Active: 2020-2026

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12630542 - Compounds and their use as therapeutically active substances in the treatment and/or prevention of diseases involving the retinal pigment epithelium (2026-05-19),

2. 12195452 - N-(4-(oxazol-5-yl)phenyl) chromane-3-carboxamide derivatives and related compounds as stimulators of the production of retinal precursor cells for the treatment of neuroretinal diseases (2025-01-14),

3. 11844755 - Compounds and their use as therapeutically active substances in the treatment and/or reducing signs or symptoms of diseases involving the retinal pigment epithelium (2023-12-19),

4. 11541039 - Compounds and their use as therapeutically active substances in the treatment and/or reducing signs or symptoms of diseases involving the retinal pigment epithelium (2023-01-03),

5. 10807973 - Compounds for use as therapeutically active substances in the treatment of retinal diseases (2020-10-20),

6. 10752593 - Compounds for use as therapeutically active substances in the treatment of retinal diseases (2020-08-25),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]

2 patents pending:

Please report any incorrect information to [email protected]

2 patents (EPO):

Please report any incorrect information to [email protected]

4 patents pending (EPO):

Please report any incorrect information to [email protected]